Logo image of GIN.DE

GIVAUDAN-REG (GIN.DE) Stock Fundamental Analysis

FRA:GIN - Deutsche Boerse Ag - CH0010645932 - Common Stock - Currency: EUR

3912  -199 (-4.84%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GIN. GIN was compared to 67 industry peers in the Chemicals industry. GIN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. GIN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year GIN was profitable.
In the past year GIN had a positive cash flow from operations.
In the past 5 years GIN has always been profitable.
In the past 5 years GIN always reported a positive cash flow from operatings.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

GIN has a Return On Assets of 9.01%. This is amongst the best in the industry. GIN outperforms 92.54% of its industry peers.
GIN's Return On Equity of 23.81% is amongst the best of the industry. GIN outperforms 97.01% of its industry peers.
GIN has a Return On Invested Capital of 13.14%. This is amongst the best in the industry. GIN outperforms 92.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GIN is above the industry average of 6.36%.
The last Return On Invested Capital (13.14%) for GIN is above the 3 year average (11.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROIC 13.14%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

GIN has a Profit Margin of 14.71%. This is amongst the best in the industry. GIN outperforms 95.52% of its industry peers.
GIN's Profit Margin has improved in the last couple of years.
The Operating Margin of GIN (18.96%) is better than 92.54% of its industry peers.
GIN's Operating Margin has improved in the last couple of years.
GIN has a better Gross Margin (44.13%) than 65.67% of its industry peers.
In the last couple of years the Gross Margin of GIN has grown nicely.
Industry RankSector Rank
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

GIN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, GIN has about the same amount of shares outstanding.
The number of shares outstanding for GIN has been increased compared to 5 years ago.
The debt/assets ratio for GIN has been reduced compared to a year ago.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

GIN has an Altman-Z score of 4.62. This indicates that GIN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GIN (4.62) is better than 89.55% of its industry peers.
GIN has a debt to FCF ratio of 3.57. This is a good value and a sign of high solvency as GIN would need 3.57 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.57, GIN belongs to the best of the industry, outperforming 86.57% of the companies in the same industry.
GIN has a Debt/Equity ratio of 0.86. This is a neutral value indicating GIN is somewhat dependend on debt financing.
GIN has a worse Debt to Equity ratio (0.86) than 71.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Altman-Z 4.62
ROIC/WACC2.83
WACC4.65%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.49 indicates that GIN should not have too much problems paying its short term obligations.
GIN's Current ratio of 1.49 is on the low side compared to the rest of the industry. GIN is outperformed by 62.69% of its industry peers.
GIN has a Quick Ratio of 1.49. This is a bad value and indicates that GIN is not financially healthy enough and could expect problems in meeting its short term obligations.
GIN has a Quick ratio (0.98) which is in line with its industry peers.
The current and quick ratio evaluation for GIN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.98
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

GIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.25%, which is quite good.
Measured over the past 5 years, GIN shows a small growth in Earnings Per Share. The EPS has been growing by 5.41% on average per year.
GIN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.19%.
GIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)15.25%
EPS 3Y10.02%
EPS 5Y5.41%
EPS Q2Q%1.73%
Revenue 1Y (TTM)7.19%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%8.73%

3.2 Future

GIN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.50% yearly.
Based on estimates for the next years, GIN will show a small growth in Revenue. The Revenue will grow by 3.89% on average per year.
EPS Next Y9.8%
EPS Next 2Y7.85%
EPS Next 3Y7.57%
EPS Next 5Y5.5%
Revenue Next Year4.12%
Revenue Next 2Y4.29%
Revenue Next 3Y4.57%
Revenue Next 5Y3.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

3

4. Valuation

4.1 Price/Earnings Ratio

GIN is valuated quite expensively with a Price/Earnings ratio of 30.20.
The rest of the industry has a similar Price/Earnings ratio as GIN.
GIN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.69.
GIN is valuated quite expensively with a Price/Forward Earnings ratio of 27.50.
GIN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. GIN is more expensive than 64.18% of the companies in the same industry.
GIN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.36.
Industry RankSector Rank
PE 30.2
Fwd PE 27.5
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

GIN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GIN is more expensive than 67.16% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GIN is valued a bit cheaper than the industry average as 62.69% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.28
EV/EBITDA 21.02
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
GIN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.08
PEG (5Y)5.58
EPS Next 2Y7.85%
EPS Next 3Y7.57%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.86%, GIN has a reasonable but not impressive dividend return.
GIN's Dividend Yield is comparable with the industry average which is at 3.14.
GIN's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.86%

5.2 History

The dividend of GIN has a limited annual growth rate of 2.07%.
Dividend Growth(5Y)2.07%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

GIN pays out 57.52% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of GIN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP57.52%
EPS Next 2Y7.85%
EPS Next 3Y7.57%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIVAUDAN-REG

FRA:GIN (7/23/2025, 7:00:00 PM)

3912

-199 (-4.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-10 2025-04-10
Earnings (Next)07-22 2025-07-22
Inst Owners34.12%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap36.11B
Analysts68.67
Price Target4499.85 (15.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.86%
Yearly Dividend72.88
Dividend Growth(5Y)2.07%
DP57.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.2
Fwd PE 27.5
P/S 4.54
P/FCF 25.28
P/OCF 20.72
P/B 7.36
P/tB N/A
EV/EBITDA 21.02
EPS(TTM)129.55
EY3.31%
EPS(NY)142.25
Fwd EY3.64%
FCF(TTM)154.74
FCFY3.96%
OCF(TTM)188.78
OCFY4.83%
SpS861.07
BVpS531.84
TBVpS-29.04
PEG (NY)3.08
PEG (5Y)5.58
Profitability
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROCE 15.16%
ROIC 13.14%
ROICexc 14.32%
ROICexgc 33.12%
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
FCFM 17.97%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
ROICexc(3y)12.12%
ROICexc(5y)11.56%
ROICexgc(3y)26.36%
ROICexgc(5y)25.23%
ROCE(3y)13.03%
ROCE(5y)12.58%
ROICexcg growth 3Y11.26%
ROICexcg growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Debt/EBITDA 2.23
Cap/Depr 81.62%
Cap/Sales 3.95%
Interest Coverage 15.27
Cash Conversion 92.12%
Profit Quality 122.2%
Current Ratio 1.49
Quick Ratio 0.98
Altman-Z 4.62
F-Score7
WACC4.65%
ROIC/WACC2.83
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)15.25%
EPS 3Y10.02%
EPS 5Y5.41%
EPS Q2Q%1.73%
EPS Next Y9.8%
EPS Next 2Y7.85%
EPS Next 3Y7.57%
EPS Next 5Y5.5%
Revenue 1Y (TTM)7.19%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%8.73%
Revenue Next Year4.12%
Revenue Next 2Y4.29%
Revenue Next 3Y4.57%
Revenue Next 5Y3.89%
EBIT growth 1Y25.45%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year30.52%
EBIT Next 3Y12.9%
EBIT Next 5Y9.39%
FCF growth 1Y45.57%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y18.35%
OCF growth 3Y8.06%
OCF growth 5Y7.42%